Drug Type Monoclonal antibody |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Ibex Biosciences LLCStartup |
Active Organization Ibex Biosciences LLCStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Squamous Intraepithelial Lesions of the Cervix | Preclinical | US | Ibex Biosciences LLCStartup | 16 Jul 2024 |
Skin Neoplasms | Preclinical | US | Ibex Biosciences LLCStartup | 31 Jan 2024 |